PenPinealon 10 mg
A short peptide bioregulator (Glu-Asp-Arg) studied for neuroprotection and brain-ageing research.
PNC-27 PENOncology research
A synthetic peptide containing a p53 domain studied for selectively targeting the HDM-2 protein on cancer-cell membranes, with research interest in oncology models.
Available to verified researchers. Pricing and the batch Certificate of Analysis are shared on request.
PNC-27 is a research peptide that incorporates a p53 fragment studied for binding HDM-2 expressed on the membranes of cancer cells, with interest in selective, membrane-directed oncology research models.
Features
PNC-27 is supplied in the NADOVA LABS GoQuick pre-filled pen — a graduated, ready-to-use subcutaneous delivery format that removes reconstitution and simplifies repeat-dose study designs. Each pen is prepared from HPLC-verified material, dose-marked on the barrel, and shipped refrigerated with a Certificate of Analysis available per batch.
Handling & compliance
This pre-filled pen is intended strictly for in-vitro and laboratory research. It is not a drug, supplement, or medical device, and is not for human or veterinary use. Store refrigerated at 2–8 °C, protect from light, and follow accepted laboratory practice; exact specifications for your lot are listed on its Certificate of Analysis.
PenA short peptide bioregulator (Glu-Asp-Arg) studied for neuroprotection and brain-ageing research.
PenA methylene-blue formulation studied for mitochondrial electron transport and neuro-research.
PenAn EPO-derived peptide studied for tissue protection and neuropathic-pain research.
Request a researcher account to view the Certificate of Analysis for this lot and place an order with the lab.